The relatively new field of protein-protein interaction (PPI) is experiencing a fantastic growth in the field of drug discovery. The key concepts of PPI are to understand how proteins interact, why inhibiting protein-protein interaction is beneficial, and how to identify molecules that block the protein-protein interactions so that treatment strategies can be formulated. 

GTCbio's upcoming 4th Protein-Protein Interaction Conference is to be held on October 25-26, 2016 inBoston, MA. This conference will have sessions that cover novel techniques, new algorithms and databases for PPIs, and potential druggable sites for disrupting protein-protein interactions. Attendees will gain an enhanced understanding of the molecular basis and inhibitor design of peptide and protein aggregation. In addition, attendees will obtain insights into the latest use of PPIs in the area of cancer research. Join this multi-disciplinary forum and network with colleagues from industry and academia to discuss the methods and tools that will ensure the most efficient and accurate optimization of protein-protein interaction.

This conference is part of our larger Protein Discovery Summit 2016 which includes four parallel conferences:

4th Protein Expression, Purification & Characterization 
4th Protein-Protein Interaction
4th Antibody & Protein Therapeutics 
2nd Antibody Drug Conjugates

1. Protein